12.94 USD
▲-0.47+3.11%
盘后 12.82 +2.13%
2026-08-03
市值
$586.77M
市盈率
—
EPS
-10.07
股息率
—
52 周区间
9.10 – 40.43
成交量
847.44K
Beta
—
目标价
32.31
52W 低 9.1052W 高 40.43
价格走势
公司简介
MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders. The company’s products include ML-007C-MA, a fixed-dose combination of an M 1 /M 4 muscarinic agonist for the treatment of schizophrenia and Alzheimer’s disease psychosis; ML-004 for the treatment of social communication deficit and/or irritability in autism spectrum disorder; ML-021 for the treatment of motor deficits in Parkinson’s disease; ML-055 for the treatment of neuropsychiatric co...